| P2093 | author name string | Andrew Poklepovic | |
| | Jane L Roberts | |
| | Laurence Booth | |
| P2860 | cites work | Novel delivery system for natural products: Nano-curcumin formulations | Q26741732 |
| | A role for G-CSF and GM-CSF in nonmyeloid cancers | Q27002515 |
| | Anticancer Efficacy of Polyphenols and Their Combinations | Q28076137 |
| | Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1 | Q28115279 |
| | Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate | Q28187453 |
| | The TNF and TNF receptor superfamilies: integrating mammalian biology | Q28203717 |
| | Nitric oxide-induced apoptosis in RAW 264.7 macrophages is mediated by endoplasmic reticulum stress pathway involving ATF6 and CHOP | Q28216242 |
| | GRP78/BiP/HSPA5/Dna K is a universal therapeutic target for human disease | Q28254667 |
| | TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis | Q28257134 |
| | RIP1, a kinase on the crossroads of a cell's decision to live or die | Q28288337 |
| | Dose escalation of a curcuminoid formulation | Q33236898 |
| | Sildenafil: a review of its use in erectile dysfunction | Q33684280 |
| | PDE5 inhibitors enhance the lethality of standard of care chemotherapy in pediatric CNS tumor cells | Q33727865 |
| | Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects | Q34069410 |
| | CCL5 and CCR5 interaction promotes cell motility in human osteosarcoma | Q34233838 |
| | Regorafenib for cancer | Q34274239 |
| | Targeting the PDGF signaling pathway in tumor treatment | Q34393461 |
| | Curcumin in cancer management: recent results of analogue design and clinical studies and desirable future research | Q34586944 |
| | The expression and prognostic impact of CXC-chemokines in stage II and III colorectal cancer epithelial and stromal tissue | Q34627786 |
| | Protein tyrosine nitration in cellular signal transduction pathways. | Q34872656 |
| | Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation | Q35279873 |
| | PDE5 inhibitors enhance celecoxib killing in multiple tumor types | Q35430943 |
| | The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts | Q35770438 |
| | PDE5 inhibitors as therapeutics for heart disease, diabetes and cancer | Q35827798 |
| | Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines | Q36204962 |
| | A CXCL1 paracrine network links cancer chemoresistance and metastasis | Q36482032 |
| | Therapeutic roles of curcumin: lessons learned from clinical trials | Q36502400 |
| | The Thr300Ala variant in ATG16L1 is associated with improved survival in human colorectal cancer and enhanced production of type I interferon | Q36682298 |
| | OSU-03012 and Viagra Treatment Inhibits the Activity of Multiple Chaperone Proteins and Disrupts the Blood-Brain Barrier: Implications for Anti-Cancer Therapies | Q36808317 |
| | Nexavar/Stivarga and viagra interact to kill tumor cells | Q36808335 |
| | Mitochondrial nitric oxide in the signaling of cell integrated responses | Q36818954 |
| | GRP78/Dna K Is a Target for Nexavar/Stivarga/Votrient in the Treatment of Human Malignancies, Viral Infections and Bacterial Diseases | Q36830763 |
| | M-CSF signals through the MAPK/ERK pathway via Sp1 to induce VEGF production and induces angiogenesis in vivo | Q36934782 |
| | The Crohn's disease: associated ATG16L1 variant and Salmonella invasion | Q36939162 |
| | Multi-kinase inhibitors can associate with heat shock proteins through their NH2-termini by which they suppress chaperone function | Q37022352 |
| | Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock | Q37138417 |
| | Tyrosine nitration of IkappaBalpha: a novel mechanism for NF-kappaB activation. | Q37183903 |
| | Reactive oxygen species in cancer | Q37431048 |
| | Multi-kinase inhibitors interact with sildenafil and ERBB1/2/4 inhibitors to kill tumor cells in vitro and in vivo | Q37457895 |
| | The inflammatory chemokine CCL5 and cancer progression | Q37541911 |
| | Nitric Oxide Synthase and Cyclooxygenase Pathways: A Complex Interplay in Cellular Signaling | Q38915140 |
| | Insidious role of nitric oxide in migration/invasion of colon cancer cells by upregulating MMP-2/9 via activation of cGMP-PKG-ERK signaling pathways | Q39379601 |
| | [Pemetrexed + Sorafenib] lethality is increased by inhibition of ERBB1/2/3-PI3K-NFκB compensatory survival signaling | Q39888747 |
| | Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation | Q39927250 |
| | PDGF-BB is a novel prognostic factor in colorectal cancer | Q39982632 |
| | Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. | Q40229198 |
| | Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways. | Q40258923 |
| | Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells | Q40372682 |
| | Endoplasmic reticulum stress as a correlate of cytotoxicity in human tumor cells exposed to diindolylmethane in vitro | Q40532508 |
| | PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide | Q42316209 |
| | Simulated microgravity promotes nitric oxide-supported angiogenesis via the iNOS-cGMP-PKG pathway in macrovascular endothelial cells | Q42989200 |
| | Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers | Q43187202 |
| | Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. | Q43670860 |
| | Mechanisms of nitric oxide independent activation of soluble guanylyl cyclase | Q44445674 |
| | Activation of constitutive nitric-oxide synthase activity is an early signaling event induced by ionizing radiation | Q44886303 |
| | Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance | Q45122000 |
| | Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells | Q45139102 |
| | M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. | Q47677525 |
| | Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. | Q51288303 |
| | A Role for the Interferon-Inducible Protein 10 in Inhibition of Angiogenesis by Interleukin-12 | Q60194037 |
| | Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer | Q72663515 |
| | Identification of IFN-gamma-producing cells in IL-12/IL-18-treated mice | Q73386230 |
| | Exogenous recombinant human IL-12 augments MHC class I antigen expression on human cancer cells in vitro | Q77584464 |
| | The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes | Q87056683 |
| P433 | issue | 59 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endoplasmic reticulum | Q79927 |
| | curcumin | Q312266 |
| P304 | page(s) | 99451-99469 | |
| P577 | publication date | 2017-08-02 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species | |
| P478 | volume | 8 | |